Early: Phase I/IIa Immunotherapybiotech cancerOncologyPhase I Case Study 15 October 2024 Guiding a biotech’s development of an immunotherapy cancer treatment with 'out-of-the-box' thinking Download PDF Share Share Share on Facebook Share on Linkedin Share on Twitter Share on Threads Share via Email Copy link to clipboard